首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Microstructure and drug-release studies of sirolimus-containing poly(lactide-co-glycolide) films.
【24h】

Microstructure and drug-release studies of sirolimus-containing poly(lactide-co-glycolide) films.

机译:含西罗莫司的聚丙交酯-乙交酯共聚物薄膜的微观结构和药物释放研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sirolimus-containing poly(lactide-co-glycolide) (PLGA) films were prepared by solution casting and removing the residual solvent, 1,4-dioxane, by liquid and supercritical carbon dioxide (CO(2) ) extraction. The effect of lactide:glycolide ratio, stereochemistry of PLGA, and extraction condition (i.e., temperature and pressure) on the polymer and drug morphologies was studied using wide-angle X-ray scattering and differential scanning calorimetry. The polymer and drug crystallinity increased after liquid and supercritical CO(2) extraction, and the level of drug crystallinity within the film depended on the extraction conditions. Generally, higher levels of drug crystallinity were observed in the films with amorphous polymer matrices, and the drug crystallinity increased with temperature and pressure of the extraction conditions. In vitro drug elution from these films was studied using a USP 4 apparatus. Polymer crystallinity was found to be the determining factor for drug release, whereby films with higher polymer crystallinity eluted less drug compared to films with amorphous polymer matrices.
机译:含西罗莫司的聚丙交酯-乙交酯共聚物(PLGA)膜是通过溶液流延并通过液体和超临界二氧化碳(CO(2))萃取除去残留溶剂1,4-二恶烷而制备的。使用广角X射线散射和差示扫描量热法研究了丙交酯:乙交酯的比率,PLGA的立体化学以及提取条件(即温度和压力)对聚合物和药物形态的影响。液体和超临界CO(2)萃取后,聚合物和药物的结晶度增加,薄膜中药物结晶度的高低取决于萃取条件。通常,在具有非晶态聚合物基质的薄膜中观察到较高的药物结晶度,并且药物结晶度随提取条件的温度和压力而增加。使用USP 4仪器研究了从这些薄膜中进行体外药物洗脱的过程。发现聚合物结晶度是药物释放的决定性因素,因此与具有无定形聚合物基质的薄膜相比,具有较高聚合物结晶度的薄膜洗脱的药物较少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号